NovelStem International Corp. (OTCPK: NSTM)
Health Care · Biotechnology · US
$0.01
-7.41% today · -47.2% 1Y
NovelStem International Corp. (OTCPK: NSTM) operates in the Biotechnology industry within the Health Care sector. The company is valued at $468.66K and employs 2 people.
Over the last twelve months the share price has lost 47.2%, trading between 0.01 and 0.04.
Tweenvest scores NovelStem International Corp. across four factors: quality 32/100, value 69/100. Its strongest factor is value.
NSTM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $468.66K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 2.80
- 52-week high
- $0.04
- 52-week low
- $0.01
- Avg volume (3M)
- —
- Shares outstanding
- 49.33M
- Employees
- 2
- Next earnings
- —
About NovelStem International Corp.
NovelStem International Corp. concentrates its efforts on pioneering and introducing diagnostic solutions for cancer treatment, specifically with the goal of mitigating chemotherapy resistance. The company, which commenced operations in 1993, was previously recognized as Hollywood Media Corp. before adopting its current name in September of 2018. Its corporate headquarters are situated in Boca Raton, Florida.
- ISIN
- US67001V1098
- Founded
- 1993
- Listed since
- Nov 12, 1993
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Biodexa Pharmaceuticals PlcNasdaqCM: BDRX | $637.92K | $0.62 | -8.30% |
| Entheon Biomedical Corp.CNSX: ENBI.X | $586.97K | CA$0.06 | +20.00% |
| Ludwig Enterprises, Inc.OTCPK: LUDG | $585.08K | $0.00 | -65.00% |
| IntegraGen SAENXTPA: ALINT | $519.56K | €0.04 | -40.00% |
| Sorrento Therapeutics, Inc.OTCPK: SRNE | $434.97K | $0.00 | +166.67% |
| Vaxil Bio Ltd.TSXV: VXL | $405.24K | CA$0.15 | -3.33% |
| Asia Green Biotechnology Corp.CNSX: ASIA | $400.48K | CA$— | — |
| Actavia Life Sciences, Inc.OTCPK: RASP | $385.91K | $— | — |
Figures last refreshed Oct 4, 2026.